Does RIVAROXABAN Cause Potentiating drug interaction? 71 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Potentiating drug interaction have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.
71
Reports of Potentiating drug interaction with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
5
Deaths
44
Hospitalizations
How Dangerous Is Potentiating drug interaction From RIVAROXABAN?
Of the 71 reports, 5 (7.0%) resulted in death, 44 (62.0%) required hospitalization, and 14 (19.7%) were considered life-threatening.
Is Potentiating drug interaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Potentiating drug interaction?
METFORMIN (150)
METHOTREXATE (119)
QUETIAPINE (98)
ASPIRIN (87)
PREGABALIN (67)
TACROLIMUS (56)
AMIODARONE (53)
CLARITHROMYCIN (52)
GABAPENTIN (52)
VINCRISTINE (52)
Which RIVAROXABAN Alternatives Have Lower Potentiating drug interaction Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM